NZ230996A - Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virus - Google Patents
Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virusInfo
- Publication number
- NZ230996A NZ230996A NZ230996A NZ23099689A NZ230996A NZ 230996 A NZ230996 A NZ 230996A NZ 230996 A NZ230996 A NZ 230996A NZ 23099689 A NZ23099689 A NZ 23099689A NZ 230996 A NZ230996 A NZ 230996A
- Authority
- NZ
- New Zealand
- Prior art keywords
- production
- against viral
- antibodies against
- recombinant polypeptides
- neutralising antibodies
- Prior art date
Links
- 241000711825 Viral hemorrhagic septicemia virus Species 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 230000003472 neutralizing effect Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 241000251468 Actinopterygii Species 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Farming Of Fish And Shellfish (AREA)
Abstract
The invention relates to new amino acid sequences comprising particularly all or part of the amino acid chain represented in figures III and IIIcontinued. These amino acids sequences may be used as active principle of a vaccine against viral hemorragic septicemy of fish.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP88402587 | 1988-10-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ230996A true NZ230996A (en) | 1991-09-25 |
Family
ID=8200430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ230996A NZ230996A (en) | 1988-10-12 | 1989-10-12 | Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virus |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0377349B1 (en) |
JP (1) | JPH04502902A (en) |
AT (1) | ATE106944T1 (en) |
AU (1) | AU4426689A (en) |
CA (1) | CA2000570A1 (en) |
DE (1) | DE68915988T2 (en) |
DK (1) | DK64691A (en) |
ES (1) | ES2055132T3 (en) |
IS (1) | IS3511A7 (en) |
NZ (1) | NZ230996A (en) |
WO (1) | WO1990004028A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0640136T3 (en) * | 1992-03-27 | 2003-09-01 | Int Flower Dev Pty Ltd | Gene sequences encoding enzymes in the flavonoid metabolic pathway with a flavonoid 3'-hydroxylase activity and their use |
EP2322656A1 (en) * | 2009-11-17 | 2011-05-18 | Centre National de la Recherche Scientifique (C.N.R.S) | Methods for diagnosing skin diseases |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2492841B1 (en) * | 1980-10-23 | 1983-07-22 | Agronomique Inst Nat Rech | MUTANT VIRUS OF VIRAL HEMORRHAGIC SEPTICEMIA, VACCINE CONTAINING THIS MUTANT, AND PROCESS FOR PREPARING THE SAME |
-
1989
- 1989-10-11 EP EP89402812A patent/EP0377349B1/en not_active Expired - Lifetime
- 1989-10-11 ES ES89402812T patent/ES2055132T3/en not_active Expired - Lifetime
- 1989-10-11 DE DE68915988T patent/DE68915988T2/en not_active Expired - Fee Related
- 1989-10-11 AT AT89402812T patent/ATE106944T1/en not_active IP Right Cessation
- 1989-10-12 IS IS3511A patent/IS3511A7/en unknown
- 1989-10-12 NZ NZ230996A patent/NZ230996A/en unknown
- 1989-10-12 AU AU44266/89A patent/AU4426689A/en not_active Abandoned
- 1989-10-12 WO PCT/EP1989/001228 patent/WO1990004028A1/en unknown
- 1989-10-12 JP JP1510993A patent/JPH04502902A/en active Pending
- 1989-10-12 CA CA002000570A patent/CA2000570A1/en not_active Abandoned
-
1991
- 1991-04-11 DK DK064691A patent/DK64691A/en unknown
Also Published As
Publication number | Publication date |
---|---|
DK64691D0 (en) | 1991-04-11 |
DE68915988T2 (en) | 1994-09-29 |
AU4426689A (en) | 1990-05-01 |
JPH04502902A (en) | 1992-05-28 |
CA2000570A1 (en) | 1990-04-12 |
ATE106944T1 (en) | 1994-06-15 |
WO1990004028A1 (en) | 1990-04-19 |
EP0377349B1 (en) | 1994-06-08 |
EP0377349A1 (en) | 1990-07-11 |
DE68915988D1 (en) | 1994-07-14 |
IS3511A7 (en) | 1990-04-13 |
DK64691A (en) | 1991-06-12 |
ES2055132T3 (en) | 1994-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK532184A (en) | ANTIGEN AMINO ACID SEQUENCES | |
ATE373010T1 (en) | GAG ANTIGEN AND ITS USE FOR DETECTING LAV INFECTION, AND IN IMMUNOGENIC COMPOSITIONS | |
HU9200548D0 (en) | Improved activity process of recombined proteins | |
EP0423224A4 (en) | Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor | |
IL90035A (en) | Synthetic multimeric hepatitis b virus vaccine including both t cell and b cell determinants | |
GR3031889T3 (en) | Lipopeptide inducing T-cytotoxic lymphocytes and their use as vaccines. | |
ZA886273B (en) | Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids | |
DK288789A (en) | PEPTIDES AND ACID ADDITION SALTS THEREOF, THEIR PREPARATION AND USE | |
IE870507L (en) | Bovine virus diarrhea and hog cholera vaccines | |
NZ230996A (en) | Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virus | |
EP0250000A3 (en) | Polypeptides, their preparation and their use | |
ES2078229T3 (en) | PROCEDURE FOR THE PREPARATION OF A POLYPEPTIDE SIMILAR TO MOTILINE AND ITS EXPRESSION. | |
DE69225473D1 (en) | POLYPEPTIDES DERIVED FROM THE ENDONUCLEASE PROTEIN OF HUMAN IMMUNE WEAKNESS VIRUS | |
DK262986A (en) | PEPTID MATERIAL WITH THYMUS HUMORAL ACTIVITY | |
EP0288198A3 (en) | Production of peptide | |
ES2033212A6 (en) | Ancrod proteins, their production and use. | |
NZ224251A (en) | Synthetic rhinovirus (hrv) peptides and vaccines | |
DK257887A (en) | PROCEDURE FOR PREPARING HBCAG IN YEARS AND PLASMID TO USE IN EXERCISE OF THE PROCEDURE | |
WO1992001794A3 (en) | Ancrod-like proteins, their preparation and their use | |
Makela | A study of the antigenicity and immunogenicity of the measles virus surface proteins | |
DK119391A (en) | HUMAN INSULIN ANALOGS | |
TH4070EX (en) | DNA sequence containing the code of P31 seraphase antigen, modified hepatitis B virus. |